Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Albuminuria

• Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
• Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
• Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - A Pilot Study
• Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria
• A Study to Assess the Effects of Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
• Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
• TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension
• SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
• Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes
• The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia
• Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
• SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
• Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
• Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
• Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
• A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
• Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
• Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
• A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
• CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
• Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
• Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
• Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
• A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD
• Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
• Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
• Influence of Aliskiren on Albuminuria After Kidney Transplantation
• Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria
• A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
• A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
• Evaluate the Efficacy of Fenofibrate on Microalbuminuria
• Use of Sitagliptin to Decrease Microalbuminuria
• Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
• A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
• Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
• A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
• Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
• A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
• A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
• Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
• Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria
• NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria
• A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria
• Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients
• Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
• ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
• Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled D
• Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
• To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
• Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
• Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients
• Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
• A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
• Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria
• Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
• Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
• To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
• Chicken-Diet vs. Enalapril to Reduce Albuminuria
• Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
• The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
• Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
• Irbesartan in Type 2 Diabetes
• Eplerenone, ACE Inhibition and Albuminuria
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
• 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria
• Aldosterone and Vascular Disease in Diabetes Mellitus
• Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
• Rationale and Design for Shiga Microalbuminuria Reduction Trial
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
• Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
• COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria
• Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria